ALL NEW PGS IVF CENTER 基因晶片試管嬰兒中心:博元婦產科邁入第三代試管嬰兒
美國紐澤西團隊,用第5天胚胎切片進行快速實時間PCR聚合酶鏈反應real-time polymerase chain reaction comprehensive chromosome screening (CCS) ,第6
所謂的第三代試管嬰兒,
博元婦產科自2010年開始,於進入基因晶片試管嬰兒中心,
1.世界第一例,漸凍人經基因晶片試管嬰兒生雙胞胎,
2.美國矽谷地中海貧血乙型,
3.第5天胚胎切片進行囊胚期胚胎切片,
以上都是基因晶片試管嬰兒中心第三代試管嬰兒中心必備的條件跟能
Blastocyst Biopsy With Comprehensive Chromosome Screening and Fresh Embryo Transfer Significantly Increases In Vitro Fertilization Implantation and Delivery Rates: a Randomized Controlled Trial
Scott RT Jr, Upham KM, Forman EJ, et al
Fertil Steril. 2013;100:697-703
This randomized, controlled trial assessed the benefits of quantitative real-time polymerase chain reaction comprehensive chromosome screening (CCS) on implantation and pregnancy rates during IVF. Women younger than 42 years who had normal ovarian function and no more than 1 previous IVF failure were eligible. In addition, the patients had to have at least 2 good-morphology blastocysts to be randomly assigned to CCS or standard care (morphologic selection).
The implantation rate was higher in the CCS group (79.8% vs 63.2%; RR: 1.26; 95% CI, 1.04-1.39). Clinical pregnancy rates were also higher in the CCS group (93.1% vs 80.7% of the cycles; RR, 1.15; 95% CI, 1.03-1.43). Delivery rates were also superior in the CCS group.